Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2026 Earnings Call Transcript January 29, 2026
Takeda Pharmaceutical Company Limited misses on earnings expectations. Reported EPS is $0.2151 EPS, expectations were $0.55.
Christopher David O’Reilly: [Interpreted] Thank you very much for taking time out of your busy schedule to join us for the earnings announcement for the third quarter FY ’25 of Takeda. I’m the MC, O’Reilly from IR. [Operator Instructions] Before starting I would like to...
